Tilray/$TLRY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tilray
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Ticker
$TLRY
Sector
Primary listing
Employees
2,842
Headquarters
Leamington, Canada
Website
Tilray Metrics
BasicAdvanced
$1.2B
-
-$2.46
1.95
-
Price and volume
Market cap
$1.2B
Beta
1.95
52-week high
$1.80
52-week low
$0.35
Average daily volume
75M
Financial strength
Current ratio
2.457
Quick ratio
1.348
Long term debt to equity
20.13
Total debt to equity
22.069
Interest coverage (TTM)
-3.63%
Profitability
EBITDA (TTM)
26.359
Gross margin (TTM)
29.49%
Net profit margin (TTM)
-266.25%
Operating margin (TTM)
-13.04%
Effective tax rate (TTM)
5.26%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-2.16%
Return on equity (TTM)
-88.44%
Valuation
Price to revenue (TTM)
1.149
Price to book
0.74
Price to tangible book (TTM)
1.52
Price to free cash flow (TTM)
-7.401
Free cash flow yield (TTM)
-13.51%
Free cash flow per share (TTM)
-0.143
Growth
Revenue change (TTM)
4.10%
Earnings per share change (TTM)
645.46%
3-year revenue growth (CAGR)
9.34%
10-year revenue growth (CAGR)
114.36%
3-year earnings per share growth (CAGR)
35.41%
10-year earnings per share growth (CAGR)
37.11%
What the Analysts think about Tilray
Analyst ratings (Buy, Hold, Sell) for Tilray stock.
Bulls say / Bears say
Tilray's international cannabis revenue jumped 71% in Q4 FY2025 and rose 19% for the year, driven by solid growth in Europe and supported by EU-GMP certified facilities in Germany and Portugal (GlobeNewswire).
Global cannabis gross margin improved by about 700 basis points to 40% in FY2025, reflecting Tilray’s effective product mix management and focus on higher-margin medical and vape offerings overseas (GlobeNewswire).
Tilray finished FY2025 with $256 million in cash and marketable securities, and repaid roughly $100 million in debt, lowering its net debt to adjusted EBITDA ratio to 0.3× and positioning itself for strategic investments (GlobeNewswire).
Tilray posted a GAAP net loss of $1.27 billion in Q4 FY2025, mainly due to a $1.40 billion non-cash impairment of goodwill and intangible assets, which overshadowed its actual operating performance (GlobeNewswire).
Net revenue for Q4 fell 2.3% year-over-year to $224.5 million, suggesting ongoing challenges in both cannabis and beverage divisions, impacted by SKU streamlining and export permit delays (Reuters).
Tilray’s industry continues to face pressure, with the valuation of leading cannabis companies—including Tilray—falling from a combined $37 billion in 2021 to only $4 billion in 2025, highlighting decreased investor confidence and stalled U.S. legalization efforts (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
Tilray Financial Performance
Revenues and expenses
Tilray Earnings Performance
Company profitability
Tilray News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tilray stock?
Tilray (TLRY) has a market cap of $1.2B as of September 12, 2025.
What is the P/E ratio for Tilray stock?
The price to earnings (P/E) ratio for Tilray (TLRY) stock is 0 as of September 12, 2025.
Does Tilray stock pay dividends?
No, Tilray (TLRY) stock does not pay dividends to its shareholders as of September 12, 2025.
When is the next Tilray dividend payment date?
Tilray (TLRY) stock does not pay dividends to its shareholders.
What is the beta indicator for Tilray?
Tilray (TLRY) has a beta rating of 1.95. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.